about
Does heart failure therapy differ according to patient sex?Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification.Statins in heart failure: the paradox between large randomized clinical trials and real life.Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).Usefulness of hospital admission risk stratification for predicting nonfatal acute myocardial infarction or death six months later in unstable angina pectoris. RESCATE Study Group. Resources Used in Acute Coronary Syndromes and Delays in Treatment.Mortality and cause of death in patients with heart failure: findings at a specialist multidisciplinary heart failure unit.Fragility is a key determinant of survival in heart failure patients.Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.Serum myostatin levels in chronic heart failure.Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure.Patient's education by nurse: what we really do achieve?Estimated creatinine clearance: a determinant prognostic factor in heart failure.[Prognostic significance of creatinine clearance rate in patients with heart failure and normal serum creatinine].[Does body mass index influence mortality in patients with heart failure?].Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.Effect of fragility on quality of life in patients with heart failure.Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.Quality of life monitoring in ambulatory heart failure patients: temporal changes and prognostic value.A novel wearable vest for tracking pulmonary congestion in acutely decompensated heart failure.Renal function largely influences Galectin-3 prognostic value in heart failure.Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.Body mass index, body fat, and nutritional status of patients with heart failure: The PLICA study.Six-month outcome in unstable angina patients without previous myocardial infarction according to the use of tertiary cardiologic resourcesSix-Month Outcome in Patients With Myocardial Infarction Initially Admitted to Tertiary and Nontertiary Hospitals fn1fn1This project was funded by Grant 92/0009 from the Fondo de Investigación Sanitaria, Madrid and by Grant CIRIT/SGR 9500167 from thUndernourishment and Prognosis in Heart FailureUsefulness of Body Mass Index to Characterize Nutritional Status in Patients With Heart FailureSoluble ST2 Serum Concentration and Renal Function in Heart FailureThe obesity paradox in heart failure: Is etiology a key factor?Myostatin serum levels in heart failureRespuestaValoración clínica, ecocardiográfica y pronóstica de la fibrilación auricular en pacientes con insuficiencia cardíacaUnidades de insuficiencia cardiaca en España: situación actualDiámetro de la aurícula izquierda: un parámetro ecocardiográfico sencillo con importante significado pronóstico en la insuficiencia cardíacaPrognostic value of segmental contractility assessed by cross-sectional echocardiography in first acute myocardial infarction[Digital angioradiography: a valid technic for the study of the permeability of coronary grafts in the immediate postoperative period][Use of the Minnesota Living With Heart Failure Quality of Life Questionnaire in Spain]Patients' self-care improvement with nurse education intervention in Spain assessed by the European Heart Failure Self-Care Behaviour ScaleSex and age differences in fragility in a heart failure population
P50
Q28212619-DC9033AD-26CE-4C72-ADD9-DBD476452F56Q34512274-526CA06D-813D-4B7F-98B2-6572EB71349AQ36522875-86945D8D-647B-4C21-B28B-C7F7F4435576Q37484132-2732097C-F433-429D-B5E3-DD47E237E212Q40789233-24584E1F-7077-457F-B726-EAF657BB19BBQ43144875-9456DE41-88B1-41F8-B0EB-16B80B03CB13Q43509121-C03806B2-EB29-4D68-9D85-881DE4F05DD2Q43719505-645AB9CE-0104-4021-8D07-FE7AE15A3901Q43975189-6C7C53E9-84BA-4AD9-B5F3-DBA37622D3FDQ44118879-F8796541-84A2-4C57-B7CD-496F831B482FQ44122782-AE75DC14-E8AA-400C-8E1C-E60F2A12D42BQ44427602-7557F727-2E36-4528-878D-9BA1B91E44F8Q46499143-CA7C9504-98F1-4AAB-B9D1-945C887618CEQ46511884-9CDD1C0C-8027-464D-9C34-B3F1348F8590Q46848920-CA12B36B-E4A8-4015-AFBA-8F92EFB69D94Q46905061-3F5A6593-98FE-4685-BE83-B164636C88EDQ47697065-96FCD406-0053-48BB-8C0C-5D432DE2EB95Q48174192-3559506C-8F81-4466-844E-BAD7BC7EB1FEQ48331571-7768FFDB-DDB5-4F37-93AE-CE18A4034DD2Q48396601-6FC1B983-393D-41A3-9A21-6519FDC2092EQ48693523-0937DC17-9357-4EFB-8E86-62403C71DDB0Q50995380-ED2D4037-3567-4E97-BEB9-D45F769CB915Q51139931-41AAB001-B3E5-49D0-98B2-475706D4788CQ53968806-351A8951-D34E-4312-9B8D-5671AAB2A9F8Q57236051-185BF96D-58A6-4F82-853F-BC647E441A59Q57236076-03A1FD0B-CB05-4B93-B799-70765B0C9BA4Q60638635-8CDE5789-F01E-466B-A117-631F342E67A7Q60638652-1DE90966-E6CD-42F6-BD87-B2D61FDD6A05Q60638746-85E0D576-9AE7-485F-8262-B904C87A28EBQ60638751-52B11183-9EA8-43BB-8D08-B167AFDDC994Q60638768-6C36A60A-EB49-4409-A735-26B30323FDA3Q60638806-DEEBC462-84CC-44D7-99AD-7F707CE5476BQ60638814-A7FB52DC-ADEA-478F-9774-6CD7C601A873Q60638816-FACFE0AD-FA4B-43FE-9298-0D24E9A25D0EQ60638817-5E981A06-5691-4931-A0EC-6C99F5E4C669Q69677611-B3383BDC-393A-448F-A6CC-14F3C4A45097Q69929517-051DF8B6-1007-4A23-8763-128C188C07C4Q76336950-37657E7C-942C-41C0-8315-F4F2E51BAAACQ80534812-72C70889-EFB0-41B1-B6BD-B01C7C3E6DFCQ81022056-4D809837-5609-4FDC-AEF0-389A70EAF6F7
P50
description
researcher ORCID 0000-0002-3981-3020
@en
wetenschapper
@nl
name
Josep Lupón
@ast
Josep Lupón
@en
Josep Lupón
@es
Josep Lupón
@nl
type
label
Josep Lupón
@ast
Josep Lupón
@en
Josep Lupón
@es
Josep Lupón
@nl
prefLabel
Josep Lupón
@ast
Josep Lupón
@en
Josep Lupón
@es
Josep Lupón
@nl
P106
P21
P31
P496
0000-0002-3981-3020